The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2000

Schlagwörter:	Ischemia Cerebral Ischaemia Cerebral Artery Middle Cerebral Artery Artery Occlusion

Anmerkung:	© Adis International Ltd 2000

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1251(2000), 1 vom: Aug., Seite 6-6
Übergeordnetes Werk:	volume:1251 ; year:2000 ; number:1 ; month:08 ; pages:6-6

Links:	Volltext

DOI / URN:	10.2165/00128413-200012510-00017

Katalog-ID:	SPR036316229

Internformat


LEADER	01000caa a22002652 4500
001	SPR036316229
003	DE-627
005	20230519191115.0
007	cr uuu---uuuuu
008	201007s2000 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200012510-00017 \|2 doi
035			\|a (DE-627)SPR036316229
035			\|a (SPR)00128413-200012510-00017-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	4	\|a The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function
264		1	\|c 2000
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2000
650		4	\|a Ischemia \|7 (dpeaa)DE-He213
650		4	\|a Cerebral Ischaemia \|7 (dpeaa)DE-He213
650		4	\|a Cerebral Artery \|7 (dpeaa)DE-He213
650		4	\|a Middle Cerebral Artery \|7 (dpeaa)DE-He213
650		4	\|a Artery Occlusion \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1251(2000), 1 vom: Aug., Seite 6-6 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1251 \|g year:2000 \|g number:1 \|g month:08 \|g pages:6-6
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200012510-00017 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1251 \|j 2000 \|e 1 \|c 08 \|h 6-6

Indexfelder

matchkey_str	article:22306056:2000----::hpoesmihbtrs1rdcsnacinnsgiiatymrv
hierarchy_sort_str	2000
publishDate	2000
allfields	10.2165/00128413-200012510-00017 doi (DE-627)SPR036316229 (SPR)00128413-200012510-00017-e DE-627 ger DE-627 rakwb eng The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Ischemia (dpeaa)DE-He213 Cerebral Ischaemia (dpeaa)DE-He213 Cerebral Artery (dpeaa)DE-He213 Middle Cerebral Artery (dpeaa)DE-He213 Artery Occlusion (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1251(2000), 1 vom: Aug., Seite 6-6 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1251 year:2000 number:1 month:08 pages:6-6 https://dx.doi.org/10.2165/00128413-200012510-00017 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1251 2000 1 08 6-6
spelling	10.2165/00128413-200012510-00017 doi (DE-627)SPR036316229 (SPR)00128413-200012510-00017-e DE-627 ger DE-627 rakwb eng The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Ischemia (dpeaa)DE-He213 Cerebral Ischaemia (dpeaa)DE-He213 Cerebral Artery (dpeaa)DE-He213 Middle Cerebral Artery (dpeaa)DE-He213 Artery Occlusion (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1251(2000), 1 vom: Aug., Seite 6-6 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1251 year:2000 number:1 month:08 pages:6-6 https://dx.doi.org/10.2165/00128413-200012510-00017 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1251 2000 1 08 6-6
allfields_unstemmed	10.2165/00128413-200012510-00017 doi (DE-627)SPR036316229 (SPR)00128413-200012510-00017-e DE-627 ger DE-627 rakwb eng The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Ischemia (dpeaa)DE-He213 Cerebral Ischaemia (dpeaa)DE-He213 Cerebral Artery (dpeaa)DE-He213 Middle Cerebral Artery (dpeaa)DE-He213 Artery Occlusion (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1251(2000), 1 vom: Aug., Seite 6-6 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1251 year:2000 number:1 month:08 pages:6-6 https://dx.doi.org/10.2165/00128413-200012510-00017 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1251 2000 1 08 6-6
allfieldsGer	10.2165/00128413-200012510-00017 doi (DE-627)SPR036316229 (SPR)00128413-200012510-00017-e DE-627 ger DE-627 rakwb eng The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Ischemia (dpeaa)DE-He213 Cerebral Ischaemia (dpeaa)DE-He213 Cerebral Artery (dpeaa)DE-He213 Middle Cerebral Artery (dpeaa)DE-He213 Artery Occlusion (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1251(2000), 1 vom: Aug., Seite 6-6 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1251 year:2000 number:1 month:08 pages:6-6 https://dx.doi.org/10.2165/00128413-200012510-00017 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1251 2000 1 08 6-6
allfieldsSound	10.2165/00128413-200012510-00017 doi (DE-627)SPR036316229 (SPR)00128413-200012510-00017-e DE-627 ger DE-627 rakwb eng The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Ischemia (dpeaa)DE-He213 Cerebral Ischaemia (dpeaa)DE-He213 Cerebral Artery (dpeaa)DE-He213 Middle Cerebral Artery (dpeaa)DE-He213 Artery Occlusion (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1251(2000), 1 vom: Aug., Seite 6-6 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1251 year:2000 number:1 month:08 pages:6-6 https://dx.doi.org/10.2165/00128413-200012510-00017 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1251 2000 1 08 6-6
language	English
source	Enthalten in Inpharma weekly 1251(2000), 1 vom: Aug., Seite 6-6 volume:1251 year:2000 number:1 month:08 pages:6-6
sourceStr	Enthalten in Inpharma weekly 1251(2000), 1 vom: Aug., Seite 6-6 volume:1251 year:2000 number:1 month:08 pages:6-6
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Ischemia Cerebral Ischaemia Cerebral Artery Middle Cerebral Artery Artery Occlusion
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2000-08-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR036316229
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036316229</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519191115.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2000 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200012510-00017</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036316229</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200012510-00017-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2000</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2000</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ischemia</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cerebral Ischaemia</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cerebral Artery</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Middle Cerebral Artery</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Artery Occlusion</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1251(2000), 1 vom: Aug., Seite 6-6</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1251</subfield><subfield code="g">year:2000</subfield><subfield code="g">number:1</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:6-6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200012510-00017</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1251</subfield><subfield code="j">2000</subfield><subfield code="e">1</subfield><subfield code="c">08</subfield><subfield code="h">6-6</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function Ischemia (dpeaa)DE-He213 Cerebral Ischaemia (dpeaa)DE-He213 Cerebral Artery (dpeaa)DE-He213 Middle Cerebral Artery (dpeaa)DE-He213 Artery Occlusion (dpeaa)DE-He213
topic	misc Ischemia misc Cerebral Ischaemia misc Cerebral Artery misc Middle Cerebral Artery misc Artery Occlusion
spellingShingle	misc Ischemia misc Cerebral Ischaemia misc Cerebral Artery misc Middle Cerebral Artery misc Artery Occlusion The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function
topic_unstemmed	misc Ischemia misc Cerebral Ischaemia misc Cerebral Artery misc Middle Cerebral Artery misc Artery Occlusion
topic_browse	misc Ischemia misc Cerebral Ischaemia misc Cerebral Artery misc Middle Cerebral Artery misc Artery Occlusion
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function
ctrlnum	(DE-627)SPR036316229 (SPR)00128413-200012510-00017-e
title_full	The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2000
contenttype_str_mv	txt
container_start_page	6
container_volume	1251
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200012510-00017
title_sort	proteasome inhibitor ps-519 reduces infarction and significantly improves neurological function
title_auth	The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function
abstract	© Adis International Ltd 2000
abstractGer	© Adis International Ltd 2000
abstract_unstemmed	© Adis International Ltd 2000
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function
url	https://dx.doi.org/10.2165/00128413-200012510-00017
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200012510-00017
up_date	2024-07-03T17:00:26.369Z
_version_	1803578010632192000
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036316229</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519191115.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2000 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200012510-00017</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036316229</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200012510-00017-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2000</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2000</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ischemia</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cerebral Ischaemia</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cerebral Artery</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Middle Cerebral Artery</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Artery Occlusion</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1251(2000), 1 vom: Aug., Seite 6-6</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1251</subfield><subfield code="g">year:2000</subfield><subfield code="g">number:1</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:6-6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200012510-00017</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1251</subfield><subfield code="j">2000</subfield><subfield code="e">1</subfield><subfield code="c">08</subfield><subfield code="h">6-6</subfield></datafield></record></collection>
score	7.4018145

Nicht das Richtige dabei?

Schreiben Sie uns!

The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?